Trial Profile
A Real-world, observational study to evaluate the safety and efficacy of empagliflozin for type 2 diabetes mellitus in Malaysian patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jan 2018
Price :
$35
*
At a glance
- Drugs Empagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 09 Jan 2018 New trial record
- 08 Dec 2017 Results presented at the 2017 Congress of the International Diabetes Federation